clinical trial · NCT07053891
LUPKYNIS Drug-use Results Survey
Otsuka Pharmaceutical Co., Ltd.·—·recruiting·n = 400
Lupus NephritisVoclosporin (LUPKYNIS)
brief summary
The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.
started
Sep 17, 2025
primary completion
Jun 30, 2031
completion
Jun 30, 2032
last updated
Sep 19, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol